idiopathic parkinson disease

Showing 1 - 25 of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Parkinson Disease Trial (MRx0029, MRx0005)

Withdrawn
  • Idiopathic Parkinson Disease
  • MRx0029
  • MRx0005
  • (no location specified)
Apr 19, 2023

Idiopathic Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in León (Adipose-derived stromal vascular fraction

Completed
  • Idiopathic Parkinson Disease
  • Parkinson's Disease and Parkinsonism
  • Adipose-derived stromal vascular fraction cells
  • León, Leon, Nicaragua
    Hospital Escuela Oscar Danilo Rosales Arguello
Jan 24, 2023

HRQoL in Parkinson's Disease Patients Patients: Role of Social

Completed
  • Parkinson Disease
  • +5 more
    • Columbus, Ohio
      The Ohio State University
    Oct 10, 2022

    Idiopathic Parkinson Disease Trial in Petach Tikva (NeuraLight software-based platform)

    Recruiting
    • Idiopathic Parkinson Disease
    • NeuraLight software-based platform
    • Petach Tikva, Israel
      Rabin Medical Center
    Aug 14, 2022

    Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,

    Not yet recruiting
    • Idiopathic Parkinson Disease
    • levodopa/carbidopa oral formulation A
    • +2 more
    • Minneapolis, Minnesota
      University of Minnesota
    Jul 20, 2022

    Parkinson Disease, Idiopathic Parkinson Disease Trial in Philadelphia ([F-18] Fluorodopa Positron Emission Tomography, OM

    Not yet recruiting
    • Parkinson Disease
    • Idiopathic Parkinson Disease
    • [F-18] Fluorodopa Positron Emission Tomography
    • OM Meditation
    • Philadelphia, Pennsylvania
      Thomas Jefferson University, Marcus Institute of Integrative Hea
    Jul 11, 2022

    Parkinson Disease, Idiopathic Parkinson Disease Trial in Philadelphia (Intravenous and Oral n-acetyl cysteine)

    Active, not recruiting
    • Parkinson Disease
    • Idiopathic Parkinson Disease
    • Intravenous and Oral n-acetyl cysteine
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jul 11, 2022

    Measuring Parkinson's Disease With Tear Fluid

    Completed
    • Idiopathic Parkinson Disease
      • Los Angeles, California
        University of Southern California
      May 5, 2022

      Idiopathic Parkinson Disease, Telerehabilitation, Physical Therapy Trial in Stockholm (Motor-cognitive exercise therapy in the

      Completed
      • Idiopathic Parkinson Disease
      • +2 more
      • Motor-cognitive exercise therapy in the home
      • Stockholm, Sweden
        Stockholms Sjukhem
      May 3, 2022

      Idiopathic Parkinson Disease Trial in Houston ([21CFR640.30] Plasma from 18 - 25 year old volunteer donors, Saline)

      Completed
      • Idiopathic Parkinson Disease
      • [21CFR640.30] Plasma from 18 - 25 year old volunteer donors
      • Saline
      • Houston, Texas
        The Neurology Center
      Dec 14, 2021

      Mitochondrial and Peroxisomal Metabolism to Differentiate

      Recruiting
      • Idiopathic Parkinson Disease
      • Parkinsonian Syndrome
      • blood collection
      • Dijon, France
        Chu Dijon Bourgogne
      Oct 26, 2021

      Parkinson's Disease-associated Spinal Disorders

      Recruiting
      • Parkinson Disease
      • Idiopathic Parkinson Disease
        • Columbus, Ohio
          Ohio State University
        Sep 13, 2021

        Parkinson's Disease Patients Treated With XADAGO (Safinamide)

        Completed
        • Idiopathic Parkinson Disease
        • XADAGO (safinamide)
        • Homewood, Alabama
        • +29 more
        Jul 9, 2021

        Idiopathic Parkinson Disease Trial in Worldwide (Safinamide Methanesulfonate, Safinamide methanesulfonate matching )

        Completed
        • Idiopathic Parkinson Disease
        • Safinamide Methanesulfonate
        • Safinamide methanesulfonate matching placebo
        • Innsbruck, Austria
        • +44 more
        May 18, 2021

        Determine Mutations in Gaucher Gene in Idiopathic Parkinson's

        Completed
        • Parkinson Disease
        • Idiopathic Parkinson Disease
          • Bad Neustadt An Der Saale, Germany
          • +14 more
          Apr 8, 2021

          Idiopathic Parkinson Disease Trial in West Lafayette, Amherst (Lee Silverman Voice Treatment, SpeechVive, Control)

          Unknown status
          • Idiopathic Parkinson Disease
          • Lee Silverman Voice Treatment
          • +2 more
          • West Lafayette, Indiana
          • +1 more
          Mar 23, 2020

          Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's

          Unknown status
          • Parkinson Disease, PARK8
          • +2 more
            • London, United Kingdom
              King's College London
            Jan 24, 2020

            Idiopathic Parkinson Disease Trial in Canada, United Kingdom, United States (Tozadenant)

            Terminated
            • Idiopathic Parkinson Disease
            • Phoenix, Arizona
            • +34 more
            Apr 9, 2019

            Idiopathic Parkinson Disease Trial in Farmington Hills (CTC-413)

            Unknown status
            • Idiopathic Parkinson Disease
            • CTC-413
            • Farmington Hills, Michigan
              Quest Research
            Apr 9, 2019

            Idiopathic Parkinson Disease Trial (glial cell line-derived neurotrophic factor)

            Completed
            • Idiopathic Parkinson Disease
            • glial cell line-derived neurotrophic factor
            • (no location specified)
            Aug 23, 2018

            Sleep, Awake & Move - Part I

            Unknown status
            • Idiopathic Parkinson Disease
              • Lugano, Switzerland
                Sleep and Epilepsy center Department of Neurology, Neurocenter o
              Aug 23, 2018

              Transdermal Rotigotine User Surveillance Study

              Completed
              • Idiopathic Parkinson Disease
                • Chomutov, Czechia
                • +210 more
                Jul 11, 2018

                Idiopathic Parkinson Disease Trial in Maisons-Alfort (CVXL-0107, Placebo, Levodopa)

                Completed
                • Idiopathic Parkinson Disease
                • Maisons-Alfort, France
                  Clevexel Pharma
                Jul 20, 2017

                Idiopathic Parkinson Disease Trial in Tours ([18F] LBT-999 PET)

                Terminated
                • Idiopathic Parkinson Disease
                • [18F] LBT-999 PET
                • Tours, France
                  University Hospital
                May 24, 2017